AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity

被引:16
|
作者
Brumpt, Eleonore [1 ]
Blagosklonov, Oleg [2 ]
Calame, Paul [1 ]
Bresson-Hadni, Solange [3 ]
Vuitton, Dominique Angele [3 ]
Delabrousse, Eric [1 ,3 ,4 ]
机构
[1] CHU Besancon, Serv Radiol, F-25000 Besancon, France
[2] CHU Besancon, Serv Med Nucl, F-250000 Besancon, France
[3] WHO Collaborating Ctr Prevent & Treatment Human E, F-25000 Besancon, France
[4] Univ Bourgogne Franche Comte, Nanomed Lab, Imagery & Therapeut, EA 4662, F-25000 Besancon, France
关键词
Alveolar echinococcosis; Calcifications; FDG-PET/CT; CT; ALVEOLAR ECHINOCOCCOSIS; FOLLOW-UP; OSTEOPONTIN; MANAGEMENT;
D O I
10.1007/s15010-019-01328-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose To correlate the presence of calcifications in alveolar echinococcosis (AE) hepatic lesions to the metabolic activity in 18 fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT). Methods Our institutional review board approved this study. 61 patients (29 women, 32 men, aged from 15 to 86 years) were included in the study. Images of FDG-PET/CT were interpreted by two independent nuclear medicine physicians. AE hepatic lesions were classified as AE lesions with or without hypermetabolic activity. The presence of calcifications was assessed on unenhanced CT scans by two independent radiologists blinded with regard to the metabolic activity of the AE hepatic lesions. Every single calcification the size of which was < 3 mm and non-measurable calcifications which were forming areas with a powdery appearance were considered as microcalcifications. All other types of calcifications were reported as macrocalcifications. Statistical analysis was performed and p value < 0.05 was considered as statistically significant. Results Microcalcifications and macrocalcifications were present at CT in 95% (58/61) AE hepatic lesions and 43% (26/61) AE hepatic lesions, respectively. Hypermetabolic activity was present at FDG-PET/CT in 93% (57/61) AE hepatic lesions. 98% (56/57) of the AE hepatic lesions presenting with hypermetabolic activity at FDG-PET/CT showed microcalcifications at CT (p = 0.01) when only 40% (23/57) showed macrocalcifications at CT (p = 0.3). 100% (23/23) of the AE hepatic lesions with hypermetabolic activity at FDG-PET/CT and macrocalcifications at CT showed also microcalcifications at CT. Conclusions Hypermetabolic activity of AE hepatic lesions at FDG-PET/CT is strongly correlated to the presence of microcalcifications at CT, independently of the presence of macrocalcifications.
引用
收藏
页码:955 / 960
页数:6
相关论文
共 50 条
  • [41] Hepatic Metastases of Gastric Adenocarcinoma Showing Metabolic Remission on FDG-PET Despite an Increase in Size on CT
    Yoon, So Young
    Kim, Sung-Yong
    Cho, Yo-Han
    Chung, Hyun Woo
    So, Young
    Lee, Hong M.
    CANCER RESEARCH AND TREATMENT, 2009, 41 (02): : 100 - 103
  • [42] Lung Segmentation and Measurements of Pulmonary Metabolic Activity with FDG-PET/CT is Reproducible in Patients with COPD
    Dogan, A.
    Christensen, T.
    Jensen, T.
    Hilberg, O.
    Juhl, C.
    Hess, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S402 - S403
  • [43] Effect of dental implants on tracer distribution in FDG-PET and FDG-PET/CT
    Beyer, T
    Müller, SP
    Terschüren, B
    Stergar, H
    Kuehl, H
    Bockisch, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S409 - S409
  • [44] FDG-PET/CT IN MULTIPLE MYELOMA A CORRELATION OF SUV AND ISS SCORE
    Ostergaard, B.
    Nielsen, A. L.
    Gerke, O.
    Mortensen, J. R.
    Asmussen, J. T.
    Ormstrup, T. E. J.
    Holdgaard, P.
    Plesner, T.
    Alavi, A.
    Hoilund-Carlsen, P. F.
    Abildgaard, N.
    HAEMATOLOGICA, 2016, 101 : 791 - 791
  • [45] Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis
    Raynor, William Y.
    Jonnakuti, Venkata S.
    Zadeh, Mahdi Zirakchian
    Werner, Thomas J.
    Cheng, Gang
    Zhuang, Hongming
    Hoilund-Carlsen, Poul Flemming
    Alavi, Abass
    Baker, Joshua F.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (12) : 2191 - 2198
  • [46] Staging in childhood lymphoma -: Differences between FDG-PET and CT
    Hermann, S
    Wormanns, D
    Pixberg, M
    Hunold, A
    Heindel, W
    Jürgens, H
    Schober, O
    Franzius, C
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (01): : 1 - 7
  • [47] Comparative operational dosimetry between FDG-PET/CT and fluorocholine PET/CT in a clinical routine practice
    Rizki, Wafaa
    Ndiaye, Lena
    Dana, Alain
    Filmont, Jean-Emmanuel
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [48] Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity?
    Kuehl, Hilmar
    Sommerwerck, Urte
    Mueller, Stefan
    van Eijk, Tina
    Bockisch, Andreas
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [49] Non-neoplastic sources of FDG-PET activity on oncologic PET/CT
    McKernan, MG
    Blake, MA
    Sahani, D
    Fischman, AJ
    Desai, HJ
    Mueller, PR
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (04) : 126 - 126
  • [50] FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT
    Nakajo, Masatoyo
    Kajiya, Yoriko
    Tani, Atushi
    Jinguji, Megumi
    Nakajo, Masayuki
    Yoshiura, Takashi
    ABDOMINAL RADIOLOGY, 2016, 41 (10) : 1891 - 1898